In the mouse tumor model, F5 T cells are exposed to NP68 cognate peptide expressed on tumor cells and to exogenously injected or tumor derived peptide on APC in spleen and LN, as evidenced by CD69 upregulation at these sites (Figures 4E–G). This evidence concerns the gene CD69 and neoplasm.